Company · CIK 1783032
Elevation Oncology, Inc.
| CIK | 1783032 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | MA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2021-08-12 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-265979 | 2022-07-01 | 2025-07-28 | 7 | |
| 333-279053 | 2024-05-02 | 2025-07-28 | 3 | |
| 333-256787 | 2021-06-04 | 2021-06-25 | 6 |
Filings
17| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2025-07-28 | EFFECTDeclared effective | 333-279053 | 9999999995-25-002367 |
| 2025-07-28 | EFFECTDeclared effective | 333-265979 | 9999999995-25-002365 |
| 2024-05-09 | EFFECTDeclared effective | 333-279053 | 9999999995-24-001460 |
| 2024-05-02 | S-3Shelf registered | 333-279053 | 0001104659-24-056028 |
| 2023-08-03 | 424B5Shelf takedown | 333-265979 | 0001558370-23-013060 |
| 2023-06-09 | 424B5Shelf takedown | 333-265979 | 0001104659-23-069976 |
| 2023-06-08 | 424B5Shelf takedown | 333-265979 | 0001104659-23-069454 |
| 2022-08-04 | EFFECTDeclared effective | 333-265979 | 9999999995-22-002255 |
| 2022-08-04 | 424B5Shelf takedown | 333-265979 | 0001558370-22-012210 |
| 2022-07-01 | S-3Shelf registered | 333-265979 | 0001558370-22-010514 |
| 2021-06-25 | 424B1Final prospectus | 333-256787 | 0001104659-21-085742 |
| 2021-06-24 | EFFECTDeclared effective | 333-256787 | 9999999995-21-002499 |
| 2021-06-23 | S-1/AAmendment | 333-256787 | 0001104659-21-084523 |
| 2021-06-21 | S-1/AAmendment | 333-256787 | 0001104659-21-082926 |
| 2021-06-16 | S-1/AAmendment | 333-256787 | 0001104659-21-081798 |
| 2021-06-04 | S-1Registration filed | 333-256787 | 0001104659-21-076988 |
| 2021-04-09 | DRSDraft made public | 377-04641 | 0001104659-21-048711 |